Beatriz E. Ribeiro
Rio De Janeiro, RJ, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The P2X7 Receptor Promotes Intestinal Fibrosis by Modulating the Gut Microbiota and the Inflammasome.
Journal: Cellular and molecular gastroenterology and hepatology
Published: October 23, 2024
The P2X7 Receptor Promotes Intestinal Fibrosis by Modulating the Gut Microbiota and the Inflammasome.
Journal: Cellular and molecular gastroenterology and hepatology
Published: October 23, 2024
P2X7 Receptor Modulation of the Gut Microbiota and the Inflammasome Determines the Severity of Toxoplasma gondii-Induced Ileitis.
Journal: Biomedicines
Published: January 19, 2023
The P2X7 Receptor Promotes Colorectal Inflammation and Tumorigenesis by Modulating Gut Microbiota and the Inflammasome.
Journal: International journal of molecular sciences
Published: March 28, 2022
Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets.
Journal: International journal of molecular sciences
Published: February 28, 2022
Bioactive Compounds from Pale Ale Beer Powder Attenuate Experimental Colitis in BALB/c Mice.
Journal: Molecules (Basel, Switzerland)
Published: December 28, 2021
Sulforaphane and Albumin Attenuate Experimental Intestinal Ischemia-Reperfusion Injury.
Journal: The Journal of surgical research
Published: September 02, 2020
Schistosoma mansoni Coinfection Attenuates Murine Toxoplasma gondii-Induced Crohn's-Like Ileitis by Preserving the Epithelial Barrier and Downregulating the Inflammatory Response.
Journal: Frontiers in immunology
Published: October 24, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026